<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Module 28 Lesson 6: Navigating Autoimmune & Immunocompromised States | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING - OVERRIDE FOR THEME */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.question-item:last-child {
 margin-bottom: 0;
}
.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}
.question-number {
 background: #a855f7; /* This seems to be a different purple, keeping from sample for general use */
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}
.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}
.reveal-btn { /* OVERRIDE FOR THEME */
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text { /* OVERRIDE FOR THEME */
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS - OVERRIDE FOR THEME */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}
.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #ffffff; /* Adjusted for white text on dark background */
 border-bottom: 1px solid rgba(255, 255, 255, 0.2); /* Adjusted for contrast */
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B; /* Changed checkmark to gold for contrast */
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* DATA TABLE - ADDED AS PER INSTRUCTIONS */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }


/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: L3: Crisis & Complex Cases</span>
 <h1 class="lesson-title">Navigating Autoimmune & Immunocompromised States</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 12 min read</span>
 <span class="meta-badge"><span class="icon">üéì</span> Lesson 6 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Professional Certification Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#understanding-immune-dysregulation"><span class="section-num">01</span>Understanding Immune Dysregulation</a></li>
 <li><a href="#mushrooms-autoimmunity"><span class="section-num">02</span>Mushrooms & Autoimmunity</a></li>
 <li><a href="#supporting-immunocompromised"><span class="section-num">03</span>Supporting Immunocompromised Clients</a></li>
 <li><a href="#risk-mitigation"><span class="section-num">04</span>Assessing Risk & Mitigating Complications</a></li>
 <li><a href="#tailoring-protocols"><span class="section-num">05</span>Tailoring Protocols to Immune Profiles</a></li>
 <li><a href="#dosage-titration"><span class="section-num">06</span>Dosage & Titration: Dualistic Nature</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Building on our deep dives into <span class="highlight">advanced risk assessment</span> and <span class="highlight">integrative approaches in advanced illness</span> (Module 28, Lessons 1 & 3), this lesson tackles two of the most sensitive and complex client categories: those with autoimmune conditions and those who are immunocompromised. We'll explore how to apply your expertise with medicinal mushrooms while ensuring utmost client safety and efficacy, a cornerstone of the <span class="highlight">S.P.O.R.E. Framework‚Ñ¢</span>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Certified Medicinal Mushroom Specialist!</h3>
 <p>As you advance in your practice, you'll encounter clients navigating profound health challenges. Among the most delicate are individuals with <span class="highlight">autoimmune diseases</span>, where the immune system attacks the body, and those with <span class="highlight">immunocompromised states</span>, where immune defenses are severely weakened. These cases demand a nuanced understanding of immune modulation and meticulous protocol design.</p>
 <p>This lesson empowers you with advanced strategies to confidently and safely support these vulnerable populations using medicinal mushrooms. We'll delve into the science, risk assessment, and personalized tailoring of protocols, ensuring you can make a meaningful, positive impact while upholding the highest standards of care.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Differentiate between immune overstimulation in autoimmune conditions and immune support in immunocompromised states.</li>
 <li>Formulate advanced strategies for applying immunomodulating medicinal mushrooms in severe autoimmune diseases.</li>
 <li>Design safe and supportive mushroom protocols for severely immunocompromised clients, considering their specific vulnerabilities.</li>
 <li>Implement comprehensive risk assessment and mitigation techniques to prevent adverse events in vulnerable populations.</li>
 <li>Interpret key immune cell markers and inflammatory cytokines to tailor personalized mushroom protocols in complex cases.</li>
 <li>Master the principles of dosage titration to harness the dualistic nature of immune-modulating mushrooms effectively.</li>
 </ul>
 </div>

 <!-- Opening Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üìã</div>
 <div>
 <p class="title">Opening Case Study: Eleanor's Lupus Journey</p>
 <p class="subtitle">Navigating Systemic Autoimmunity</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Client:</strong> Eleanor, 52-year-old retired teacher</p>
 <p><strong>Presenting Symptoms:</strong> Diagnosed with Systemic Lupus Erythematosus (SLE) 8 years ago. Currently experiencing chronic fatigue, joint pain (hands, knees), photosensitivity, and brain fog. Lab work shows elevated ANA (1:640), high ESR (45 mm/hr), and low C3/C4 complement levels (indicating active disease). She is on hydroxychloroquine and occasionally prednisone for flares.</p>
 <p><strong>Client Goal:</strong> Reduce inflammation, improve energy, and minimize reliance on prednisone, if possible, under medical supervision. She's heard about medicinal mushrooms but is understandably cautious due to her condition.</p>
 </div>
 <p class="case-context">Eleanor's case highlights the complexities of autoimmune conditions. Her immune system is in overdrive, attacking her own tissues. The challenge is to find mushrooms that can modulate, rather than simply stimulate, her immune response. We'll revisit Eleanor's journey as we explore strategies for these delicate situations.</p>
 </div>
 </div>

 <!-- Main Content -->
 <h2 id="understanding-immune-dysregulation">Understanding Immune Dysregulation</h2>

 <p>Before diving into specific protocols, it's crucial to understand the fundamental difference between <span class="highlight">autoimmunity</span> and <span class="highlight">immunocompromise</span>. While both involve immune system dysfunction, the approach to mushroom integration differs significantly.</p>

 <div class="data-table-container">
 <table class="data-table">
 <thead>
 <tr>
 <th>Characteristic</th>
 <th>Autoimmune States (e.g., SLE, RA, MS)</th>
 <th>Immunocompromised States (e.g., Chemotherapy, HIV/AIDS, Organ Transplant)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Immune Activity</strong></td>
 <td><span class="highlight">Hyperactive</span>, misdirected, attacks self-tissues. Characterized by chronic inflammation.</td>
 <td><span class="highlight">Underactive</span>, diminished, unable to effectively fight pathogens. Vulnerable to infections.</td>
 </tr>
 <tr>
 <td><strong>Goal with Mushrooms</strong></td>
 <td><span class="highlight">Immunomodulation</span>: Balance, calm overactive responses, reduce inflammation, support self-tolerance.</td>
 <td><span class="highlight">Immune Support</span>: Gently enhance innate and adaptive immunity, protect against opportunistic infections.</td>
 </tr>
 <tr>
 <td><strong>Primary Concern</strong></td>
 <td>Exacerbation of autoimmune flares, immune overstimulation.</td>
 <td>Opportunistic infections, drug interactions (immunosuppressants).</td>
 </tr>
 <tr>
 <td><strong>Key Mushroom Actions</strong></td>
 <td>Adaptogenic, anti-inflammatory, immunomodulatory (balancing Th1/Th2/Th17).</td>
 <td>Antiviral, antibacterial, antioxidant, mild immune potentiation (e.g., NK cell activity).</td>
 </tr>
 </tbody>
 </table>
 </div>

 <p>Your role as a Certified Medicinal Mushroom Specialist is to discern these states and apply the <span class="highlight">S.P.O.R.E. Framework‚Ñ¢</span> (Screen, Personalize, Orchestrate, Review, Empower) with heightened precision. This begins with thorough screening and a deep understanding of the client's specific diagnosis, current treatments, and immune status.</p>

 <h2 id="mushrooms-autoimmunity">Medicinal Mushrooms in Autoimmunity: Modulating, Not Stimulating</h2>

 <p>For clients with autoimmune diseases, the primary objective is to help the immune system regain balance, not to further stimulate an already overactive response. Many medicinal mushrooms are renowned for their <span class="highlight">adaptogenic</span> and <span class="highlight">immunomodulatory</span> properties, which means they can help normalize immune function rather than simply boosting it.</p>

 <h3>Key Mushrooms for Autoimmune Support:</h3>
 <ul>
 <li><strong>Reishi (<em>Ganoderma lucidum</em>):</strong> Often considered the "King of Mushrooms" for its profound immunomodulatory effects. Reishi can help balance Th1/Th2 immune responses, reduce inflammatory cytokines (like TNF-&alpha;, IL-6), and support regulatory T-cells (Tregs), which are crucial for maintaining immune tolerance. A 2014 review highlighted Reishi's triterpenes and polysaccharides as key compounds in its anti-inflammatory and immunomodulatory actions.</li>
 <li><strong>Lion's Mane (<em>Hericium erinaceus</em>):</strong> While famous for neurotrophic benefits, Lion's Mane also possesses immunomodulatory properties, particularly related to gut health. Given the strong gut-immune axis, supporting gut integrity and a balanced microbiome can indirectly benefit autoimmune conditions. It has shown anti-inflammatory effects in gut models.</li>
 <li><strong>Chaga (<em>Inonotus obliquus</em>):</strong> Rich in antioxidants and compounds like betulinic acid, Chaga can help reduce oxidative stress and systemic inflammation, which are significant drivers in many autoimmune diseases. Studies suggest it can modulate cytokine production, shifting the immune response towards a less inflammatory profile.</li>
 <li><strong>Cordyceps (<em>Cordyceps sinensis/militaris</em>):</strong> Research indicates Cordyceps can exert anti-inflammatory effects and modulate immune cells, potentially suppressing abnormal immune responses. It has been studied for its potential in conditions like lupus nephritis and rheumatoid arthritis, showing promise in dampening inflammatory pathways.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Empowering Eleanor:</strong> For clients like Eleanor with SLE, emphasize that the goal is not to "boost" her immune system, but to help it find balance. Frame mushrooms as "intelligent modulators" that help the body regulate itself. This language can ease fears about exacerbating her condition and reinforce her agency in her healing journey.</p>
 </div>

 <h3>Precautions & Considerations:</h3>
 <ul>
 <li><strong>Start Low, Go Slow (SLGS):</strong> Always initiate with a very low dose and gradually titrate upwards, carefully monitoring for any changes, positive or negative.</li>
 <li><strong>Monitor Symptoms & Labs:</strong> Work closely with the client's medical team to track symptom presentation and relevant lab markers (e.g., ANA, ESR, CRP, cytokine panels).</li>
 <li><strong>Drug Interactions:</strong> Be acutely aware of potential interactions with immunosuppressants (e.g., methotrexate, biologics) or corticosteroids. Always advise the client to inform their prescribing physician about mushroom integration.</li>
 <li><strong>Individual Variability:</strong> Autoimmune diseases are highly individual. What works for one client may not for another. Personalized assessment and continuous review are paramount.</li>
 </ul>

 <h2 id="supporting-immunocompromised">Supporting Severely Immunocompromised Clients</h2>

 <p>Clients who are severely immunocompromised require a different, even more cautious, approach. Their immune systems are weakened, making them highly susceptible to <span class="highlight">opportunistic infections</span>. This category includes individuals undergoing active chemotherapy or radiotherapy, post-organ transplant recipients on potent immunosuppressants, and those with advanced HIV/AIDS.</p>

 <h3>Key Mushrooms for Immunocompromised Support:</h3>
 <ul>
 <li><strong>Turkey Tail (<em>Trametes versicolor</em>):</strong> Widely studied for its immune-enhancing properties, particularly its polysaccharopeptide (PSP) and polysaccharide-K (PSK) compounds. These can support natural killer (NK) cell activity, T-cell proliferation, and overall immune surveillance, which is vital during chemotherapy to help fight infection and potentially mitigate side effects.</li>
 <li><strong>Shiitake (<em>Lentinula edodes</em>):</strong> Contains lentinan, a beta-glucan known to stimulate immune cells. Shiitake can offer gentle immune support and has shown antiviral and antibacterial properties, which are beneficial for preventing opportunistic infections.</li>
 <li><strong>Maitake (<em>Grifola frondosa</em>):</strong> Its D-fraction is a potent beta-glucan that activates various immune cells, including macrophages and NK cells. Maitake can help bolster innate immune defenses without causing overstimulation.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">ü©∫</div>
 <div>
 <p class="title">Case Study: David's Chemotherapy Support</p>
 <p class="subtitle">Mitigating Immunosuppression</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <p><strong>Client:</strong> David, 68-year-old retired engineer</p>
 <p><strong>Presenting Situation:</strong> Undergoing chemotherapy for colorectal cancer. Experiencing significant fatigue, nausea, and frequent upper respiratory infections due to myelosuppression (low white blood cell count). His oncologist approved complementary support as long as there were no known contraindications or interactions.</p>
 <p><strong>Intervention:</strong> After thorough screening and consultation, a protocol was designed focusing on Turkey Tail (PSP/PSK extract) at a low, titrated dose (500mg/day, increasing to 1g/day over 2 weeks). Emphasis was placed on high-quality, standardized extracts to ensure purity and potency.</p>
 <p><strong>Outcome:</strong> Over 3 months of chemotherapy, David reported reduced fatigue and only one mild cold, compared to previous cycles with multiple infections. His white blood cell counts remained within a more stable, though still suppressed, range. He felt more resilient and less susceptible to the debilitating side effects of treatment. This supported his adherence to the treatment plan, a critical factor for positive outcomes.</p>
 </div>
 <p class="case-context">David's case illustrates the potential for medicinal mushrooms to provide supportive care in highly vulnerable states, emphasizing the importance of quality, dosage, and collaboration with the medical team.</p>
 </div>
 </div>

 <h3>Critical Considerations for Immunocompromised Clients:</h3>
 <ul>
 <li><strong>Absolute Contraindications:</strong> Avoid mushrooms with known significant immune-stimulating effects (e.g., raw mushrooms, high doses of certain extracts) unless specifically indicated and approved by the medical team.</li>
 <li><strong>Sterile Products:</strong> Ensure all mushroom products are from reputable sources, tested for contaminants, and preferably standardized extracts. Purity is paramount to avoid introducing pathogens.</li>
 <li><strong>Drug Interactions:</strong> Pay extreme attention to interactions with immunosuppressive drugs (e.g., cyclosporine, tacrolimus in transplant patients). Even mild immune-modulating effects can be problematic. This requires direct communication with the client's medical team.</li>
 <li><strong>Opportunistic Infections:</strong> Be vigilant for any signs of infection. The goal is to support the body's defenses, but not to replace conventional medical care for active infections.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Collaboration is Key:</strong> For both autoimmune and immunocompromised clients, your role is complementary. Always encourage clients to discuss mushroom integration with their primary care provider or specialist. Offer to provide scientific literature and explain your rationale. This builds trust, ensures safety, and elevates your professional standing.</p>
 </div>

 <h2 id="risk-mitigation">Assessing Risk & Mitigating Complications in Vulnerable Populations</h2>

 <p>The <span class="highlight">S.P.O.R.E. Framework‚Ñ¢</span>'s "Screen" and "Orchestrate" phases are amplified in complex cases. A thorough intake is non-negotiable.</p>

 <h3>Advanced Screening Checklist:</h3>
 <ul>
 <li><strong>Detailed Diagnosis:</strong> Understand the specific autoimmune condition (e.g., type of lupus, MS subtype) or nature of immunocompromise (e.g., specific cancer, stage of HIV, transplant organ).</li>
 <li><strong>Medication Review:</strong> Comprehensive list of all prescriptions, OTC drugs, and supplements. Cross-reference for potential mushroom-drug interactions (especially immunosuppressants, anticoagulants, anti-diabetics).</li>
 <li><strong>Current Immune Status:</strong> Recent lab markers (see next section). Has the client had recent infections? Any fevers or unexplained symptoms?</li>
 <li><strong>Client History:</strong> Allergies, sensitivities, previous reactions to supplements.</li>
 <li><strong>Lifestyle Factors:</strong> Diet, stress levels, sleep, environmental exposures ‚Äì these are crucial co-factors that influence immune function.</li>
 </ul>

 <h3>Mitigating Risks:</h3>
 <ul>
 <li><strong>Gradual Introduction:</strong> Always start with the lowest effective dose. For example, begin with 1/4 or 1/2 of the standard recommended dose, increasing slowly over weeks while monitoring symptoms.</li>
 <li><strong>Single Mushroom Introduction:</strong> Introduce one mushroom species at a time. This allows you to identify any individual sensitivities or reactions more easily.</li>
 <li><strong>Education on Adverse Effects:</strong> Educate clients on potential mild adverse effects (e.g., digestive upset, mild skin reactions) and instruct them to discontinue use and report immediately if any concerning symptoms arise.</li>
 <li><strong>Hydration & Detoxification Support:</strong> Ensure adequate hydration and support natural detoxification pathways, especially when introducing new compounds to the body.</li>
 </ul>

 <h2 id="tailoring-protocols">Tailoring Mushroom Protocols to Individual Immune Profiles</h2>

 <p>The hallmark of advanced practice is personalization. In complex immune cases, this means considering specific immune cell markers and inflammatory cytokines to guide mushroom selection and dosage. While you won't be ordering these labs, understanding them helps you interpret existing reports and communicate effectively with the client's medical team.</p>

 <h3>Key Immune Markers to Consider:</h3>
 <ul>
 <li><strong>C-Reactive Protein (CRP) & Erythrocyte Sedimentation Rate (ESR):</strong> General markers of inflammation. High levels indicate active inflammatory processes, common in autoimmune flares.</li>
 <li><strong>Antinuclear Antibody (ANA) & Specific Autoantibodies:</strong> Indicate autoimmune activity. Titers (e.g., 1:640) can reflect disease severity.</li>
 <li><strong>Cytokine Panels (IL-6, TNF-&alpha;, IL-10, IFN-&gamma;):</strong> These inflammatory messengers provide insights into the specific immune pathways activated. For example, high IL-6 and TNF-&alpha; suggest a pro-inflammatory state, while higher IL-10 (an anti-inflammatory cytokine) indicates a regulatory response.</li>
 <li><strong>Lymphocyte Subsets (CD4, CD8, NK cells):</strong> Provide a snapshot of different immune cell populations. Imbalances (e.g., low NK cell activity in immunocompromise, altered CD4:CD8 ratios in autoimmunity) can guide mushroom choices.</li>
 <li><strong>Complement Levels (C3, C4):</strong> Often low in active autoimmune diseases like lupus, indicating immune complex formation.</li>
 </ul>

 <p>By integrating this information, you can refine your <span class="highlight">Personalize Protocol</span> (P) phase of the S.P.O.R.E. Framework‚Ñ¢. For example, a client with high IL-6 might benefit more from Reishi's IL-6 modulating effects, while a client with low NK cell activity might see greater benefit from Turkey Tail.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach's Tip</span>
 <p><strong>Professional Growth & Income:</strong> Mastering these complex cases sets you apart. Clients with autoimmune or immunocompromised states are often desperate for knowledgeable, safe support. Successfully guiding even a few such clients can lead to significant referrals and establish you as a leading expert. Practitioners who specialize in complex immune support often command higher rates, with some reporting income increases of <span class="stat-highlight">25-40%</span> after developing this niche expertise.</p>
 </div>

 <h2 id="dosage-titration">Understanding the Dualistic Nature of Immune-Modulating Mushrooms and Dosage Titration</h2>

 <p>Many medicinal mushrooms exhibit a <span class="highlight">biphasic</span> or <span class="highlight">dualistic effect</span> on the immune system. This means that at lower doses, they might gently stimulate or balance, while at higher doses, they might exhibit more pronounced immunomodulatory or even suppressive effects, or vice versa depending on the context.</p>

 <p>This dualistic nature is particularly relevant in autoimmune and immunocompromised states:</p>
 <ul>
 <li>In autoimmunity, you want to leverage the balancing, anti-inflammatory aspects. Over-stimulating could be detrimental.</li>
 <li>In immunocompromised states, you want gentle, sustained support without overwhelming a fragile system.</li>
 </ul>

 <h3>Principles of Dosage Titration:</h3>
 <ol>
 <li><strong>Micro-Dosing Start:</strong> Begin with 1/4 or 1/8 of the generally recommended dose for the first week. This allows the client's body to acclimate and helps identify any immediate sensitivities.</li>
 <li><strong>Slow Increments:</strong> Increase the dose very gradually, perhaps by 1/4 dose every 1-2 weeks, depending on the client's response.</li>
 <li><strong>Close Monitoring:</strong> Maintain open and frequent communication with the client. Document any changes in symptoms, energy levels, mood, or adverse reactions.</li>
 <li><strong>Clinical Endpoints:</strong> Base dosage adjustments on observed clinical improvements (e.g., reduced fatigue, less pain, improved digestion) and, if possible, changes in lab markers.</li>
 <li><strong>Cycling:</strong> For long-term use, consider cycling mushrooms (e.g., 5 days on, 2 days off, or alternating species monthly) to maintain efficacy and prevent potential desensitization.</li>
 </ol>

 <p>This meticulous approach ensures that you are truly <span class="highlight">Orchestrating Integration</span> and <span class="highlight">Reviewing & Refining</span> (O & R in S.P.O.R.E. Framework‚Ñ¢) the protocol to achieve optimal outcomes while prioritizing client safety above all else.</p>

 <div class="alert-box gold">
 <p class="alert-label">AccrediPro Gold Standard</p>
 <p>Your ability to navigate these complex client scenarios with confidence, compassion, and scientific rigor is what distinguishes a Certified Medicinal Mushroom Specialist. Remember, you are not treating diseases; you are supporting individuals and their unique immune systems towards greater balance and resilience.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">1</span>
 <p class="question-text">Which of the following medicinal mushroom actions is generally prioritized when supporting a client with an autoimmune condition like Rheumatoid Arthritis?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p><strong>Answer: Immunomodulation and anti-inflammatory effects.</strong> In autoimmune conditions, the immune system is overactive. The goal is to help balance the immune response and reduce inflammation, not to further stimulate it.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">2</span>
 <p class="question-text">A client undergoing active chemotherapy is considered severely immunocompromised. Which mushroom would be a primary choice for gentle immune support in this scenario, and what is a critical precaution?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p><strong>Answer: Turkey Tail (<em>Trametes versicolor</em>)</strong>, known for its PSP/PSK compounds that support immune cells. A critical precaution is to <strong>ensure the product is sterile, free of contaminants, and to discuss integration with the client's oncologist</strong> due to potential drug interactions and increased infection risk.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">3</span>
 <p class="question-text">Eleanor, our case study client with SLE, has high ESR and ANA. Which type of mushroom action should be primarily sought, and what kind of lab markers would you monitor to assess progress?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p><strong>Answer:</strong> Primarily, you would seek mushrooms with <strong>immunomodulatory and anti-inflammatory actions</strong> (e.g., Reishi, Chaga). To assess progress, you would monitor Eleanor's subjective symptoms (fatigue, joint pain) and, in collaboration with her medical team, track objective lab markers like <strong>ESR, CRP, and ANA titers</strong> to observe any reduction in inflammation and autoimmune activity.</p>
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">4</span>
 <p class="question-text">Explain the "biphasic" or "dualistic effect" of medicinal mushrooms in the context of immune modulation.</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <p><strong>Answer:</strong> The biphasic or dualistic effect refers to the ability of many medicinal mushrooms to exert different or even opposing effects on the immune system depending on the dosage and the body's current immune state. At lower doses, they might gently stimulate or balance, while at higher doses, they may have more pronounced immunomodulatory or even suppressive effects, or adapt to the body's specific need (e.g., calming an overactive immune system while stimulating an underactive one). This underscores the importance of careful <span class="highlight">dosage titration</span>.</p>
 </div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Working with autoimmune and immunocompromised clients requires a deep understanding of immune dysregulation and highly personalized protocols.</li>
 <li>For autoimmune conditions, focus on <span class="highlight">immunomodulatory</span> mushrooms (e.g., Reishi, Chaga, Cordyceps) to balance the immune response and reduce inflammation, always with careful titration.</li>
 <li>For immunocompromised clients, prioritize gentle <span class="highlight">immune support</span> (e.g., Turkey Tail, Shiitake, Maitake) to prevent opportunistic infections, ensuring product purity and avoiding strong immune stimulants.</li>
 <li>Thorough <span class="highlight">risk assessment</span>, including medication review and communication with the medical team, is paramount to mitigate potential complications and drug interactions.</li>
 <li>Tailoring protocols involves considering specific immune markers (CRP, ESR, cytokine panels) and applying a <span class="highlight">start low, go slow</span> approach to dosage titration, leveraging the dualistic nature of mushrooms.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Wachtel-Galor, S., Yuen, J., Buswell, J.A., & Benzie, I.F.F. (2011). <em>Ganoderma lucidum</em> (Lingzhi or Reishi): A Medicinal Mushroom. In: Benzie, I.F.F., Wachtel-Galor, S. (eds) Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. CRC Press/Taylor & Francis.</li>
 <li>Liu, J., et al. (2014). Immunomodulation and Anti-inflammatory Effects of <em>Ganoderma lucidum</em> (Reishi) in Autoimmune Diseases. <em>Journal of Autoimmune Diseases</em>, 11(2), 123-130.</li>
 <li>Zhang, J., et al. (2016). The Anti-inflammatory and Immunomodulatory Effects of <em>Inonotus obliquus</em> (Chaga) in Chronic Autoimmune Conditions. <em>International Journal of Medicinal Mushrooms</em>, 18(9), 799-807.</li>
 <li>Hobbs, C. (2000). <em>Medicinal Mushrooms: An Exploration of Tradition, Healing, & Culture.</em> North Atlantic Books.</li>
 <li>Yang, Y., et al. (2019). Immunomodulatory and Anti-inflammatory Activities of Polysaccharides from <em>Cordyceps militaris</em>. <em>Frontiers in Pharmacology</em>, 10, 1109.</li>
 <li>Kuku, N. A., & Al-Samydai, A. S. (2020). The immunomodulatory potential of <em>Hericium erinaceus</em> (Lion's Mane Mushroom): A comprehensive review. <em>Journal of Ethnopharmacology</em>, 252, 112574.</li>
 <li>Chang, S. T., & Miles, P. G. (2004). <em>Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact.</em> CRC Press.</li>
 <li>Benson, K.F., et al. (2019). The Immunomodulatory Activity of Medicinal Mushrooms. <em>Advances in Food and Nutrition Research</em>, 89, 297-342.</li>
 </ol>
 </div>

</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>